Learn about targeted therapies designed to attack certain breast cancer cells. Targeted therapies include trastuzumab (Herceptin), pertuzumab (Perjeta) and lapatinib (Tykerb).

Dec 2, 2025 · Some of these targeted therapy drugs, such as trastuzumab and trastuzumab deruxtecan, may also be used for HER-low breast cancer. HER2-low breast cancers have a small amount of …

Aug 10, 2021 · Targeted therapy for HER2-positive breast cancer In about 15% to 20% of breast cancers, the cancer cells make too much of a growth-promoting protein known as HER2. These …

Jan 15, 2025 · Anti-HER2 therapies (also called HER2 inhibitors or HER2-targeted therapies) are a class of medicines used to treat all stages of HER2-positive breast cancer, from early-stage to metastatic, …

Jul 24, 2024 · What are HER2-targeted therapies? Traditional chemotherapy, radiation and surgery still play an important role in the treatment of HER2-positive cancers. These treatments often are used …

18 hours ago · The drug targets the HER2 protein with trastuzumab, and the deruxtecan (drug/payload) component attached to the antibody kills the cancer cells. PI3K/AKT/mTOR Pathway Inhibitor

Targeted therapies—a form of precision medicine—have represented some of the most important breakthroughs in breast cancer research. Today, oncologists have numerous targeted therapies to …

Apr 17, 2025 · How do breast cancer biologic targeted therapies work? Breast cancer biologic targeted therapy uses drugs that block the growth of breast cancer cells in specific ways. For example, …

2 days ago · The efficacy of contemporary cancer treatments can be attributed to novel targeted and immunotherapeutic agents capable of selectively targeting cancer cells, such as CDK4/6 inhibitor—a …

In the case of HER2+ breast cancer with positive hormone receptors (luminal B), endocrine therapy is incorporated into the trastuzumab and chemotherapy administration [13, 14]. There are several …